Molecure – homepage
Logo of the National Centre for Research and Development (external link) Logo of the European Funds (external link)
Molecure
  • Home
  • About
    • About Molecure S.A.
    • Our Team
  • R&D
    • Pipeline
    • Targeting Unexplored Proteins
    • Unique RNA Platform
    • Publications
    • Posters
    • Research Partnerships
  • Patients
  • Investors & media
    • Investor Overview
    • Shareholder Information
    • Financial information
    • Investor Relations
    • News & events
  • Careers
    • Overview
    • Our Culture
    • Rewards & Benefits
    • Current Opportunities
  • Contact
    • Whistleblowers
  • PL
  • EN

Category: Publications

Structure-Based Discovery of High-Affinity Small Molecule Ligands and Development of Tool Probes to Study the Role of Chitinase-3-Like Protein 1

Inhibition of Macrophage-Specific CHIT1 as an Approach to Treat Airway Remodeling in Severe Asthma

Pharmacological Inhibition of Chitotriosidase (CHIT1) as a Novel Therapeutic Approach for Sarcoidosis

OATD-02 Validates the Benefits of Pharmacological Inhibition of Arginase 1 and 2 in Cancer

Inhibition of CHIT1 as a novel therapeutic approach in idiopathic pulmonary fibrosis

Development of Dual Chitinase Inhibitors as Potential New Treatment for Respiratory System Diseases

Benzoxazepine-Derived Selective, Orally Bioavailable Inhibitor of Human Acidic Mammalian Chitinase

Targeting Acidic Mammalian chitinase Is Effective in Animal Model of Asthma

Discovery and Pharmacokinetics of Sulfamides and Guanidines as Potent Human Arginase 1 Inhibitors

Posts navigation

Older posts
Newer posts
Molecure logo – Homepage

About us

Molecure is an innovative biotechnology company dedicated to discovering, developing and commercializing novel therapeutics for neoplastic and inflammatory diseases.
Facebook – external link X (Twitter) – external link LinkedIn – external link